Next Article in Journal
Developing a Research Instrument to Document Awareness, Knowledge, and Attitudes Regarding Breast Cancer and Early Detection Techniques for Pakistani Women: The Breast Cancer Inventory (BCI)
Next Article in Special Issue
Biomarkers in Lysosomal Storage Diseases
Previous Article in Journal
Association between Low Serum Bicarbonate Concentrations and Cardiovascular Disease in Patients in the End-Stage of Renal Disease
Previous Article in Special Issue
Genetic Substrate Reduction Therapy: A Promising Approach for Lysosomal Storage Disorders

Integrative Systems Biology Investigation of Fabry Disease

Institute of Cardiovascular and Medical Sciences, BHF Glasgow Cardiovascular Research Centre, University of Glasgow, 126 University Place, Glasgow, G12 8TA, UK
Author to whom correspondence should be addressed.
Academic Editor: Jose A. Sanchez-Alcazar
Diseases 2016, 4(4), 35;
Received: 1 September 2016 / Revised: 2 November 2016 / Accepted: 10 November 2016 / Published: 15 November 2016
(This article belongs to the Collection Lysosomal Storage Diseases)
Fabry disease (FD) is a rare X-linked recessive genetic disorder caused by a deficient activity of the lysosomal enzyme alpha-galactosidase A (GLA) and is characterised by intra-lysosomal accumulation of globotriaosylceramide (Gb3). We performed a meta-analysis of peer-reviewed publications including high-throughput omics technologies including naïve patients and those undergoing enzyme replacement therapy (ERT). This study describes FD on a systems level using a systems biology approach, in which molecular data sourced from multi-omics studies is extracted from the literature and integrated as a whole in order to reveal the biochemical processes and molecular pathways potentially affected by the dysregulation of differentially expressed molecules. In this way new insights are provided that describe the pathophysiology of this rare disease. Using gene ontology and pathway term clustering, FD displays the involvement of major biological processes such as the acute inflammatory response, regulation of wound healing, extracellular matrix (ECM) remodelling, regulation of peptidase activity, and cellular response to reactive oxygen species (ROS). Differential expression of acute-phase response proteins in the groups of naïve (up-regulation of ORM1, ORM2, ITIH4, SERPINA3 and FGA) and ERT (down-regulation of FGA, ORM1 and ORM2) patients could be potential hallmarks for distinction of these two patient groups. View Full-Text
Keywords: Anderson-Fabry Disease; omics; data integration; disease modelling Anderson-Fabry Disease; omics; data integration; disease modelling
Show Figures

Graphical abstract

MDPI and ACS Style

Fernandes, M.; Husi, H. Integrative Systems Biology Investigation of Fabry Disease. Diseases 2016, 4, 35.

AMA Style

Fernandes M, Husi H. Integrative Systems Biology Investigation of Fabry Disease. Diseases. 2016; 4(4):35.

Chicago/Turabian Style

Fernandes, Marco, and Holger Husi. 2016. "Integrative Systems Biology Investigation of Fabry Disease" Diseases 4, no. 4: 35.

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

Back to TopTop